Developed initially by one of the first medical institutions to launch next generation sequencing tests for cancer and complex inherited diseases, be ready to experience the most streamlined and clinically integrated software for the analysis, reporting, and delivery of genomic insights for more precise patient care.
A powerful rules engine delivers the richest set of expertly curated genomic data, clinical practice guidelines, FDA therapeutics, clinical trials, and medical interpretations from your institution and other PierianDx customers so you can be confident that the results you deliver are clinically actionable, timely and complete.
Developed for clinical laboratories by clinical laboratories, PierianDx's Clinical Genomics Workspace provides complete informatics, genomic interpretation, and reporting workflow support for cancer and germline molecular diagnostic testing applications.
The layout, content, and delivery of molecular reports are critical for timely and effective patient care. PierianDx's Clinical Genomics Workspace supports customizable and standardized reporting to ensure adherence with industry guidelines, while also making reports easy to understand and act upon by oncologists and other providers.
PierianDx's API and HL7 interfaces enable seamless integration with your institution's electronic medical record (EMR), laboratory information system (LIS), and enterprise data warehouse (EDW) to ensure results are delivered in the most timely and useable format and that genomic data are utilized more effectively throughout your health system.
To speed analysis and to ensure you are delivering the highest quality reporting of next generation sequencing data, Clinical Genomics Workspace provides a robust and powerful set of quality control, data visualization, variant classification/prioritization, and data aggregation tools.
Consider our team your team. With over 200 years of combined clinical genomics experience, we have an expertly trained staff of clinical bioinformaticists, variant scientists, implementation specialists, and a board certified medical director ready to help you build the most advanced genomic testing and precision medicine programs.
With over 150 unique and diverse next generation sequencing panels deployed on behalf of our customers, we have the experience you need to build the most clinically effective test menu for your institution. Our technology is sequencing platform agnostic and supports all chemistries and variant types for cancer and germline testing.
Learn how Dartmouth-Hitchcock and others have successfully brought next generation sequence testing in-house with PierianDx software and services.View Webinar →
Panelists discuss the design of the assay, data analytics, and reasons behind their selection of the TST170 assay, and will share details of how it is being utilized within their organizations.View Webinar →